CDKN1B and prostate cancer: The oncogenic role of E6AP in prostate cancer is also associated with ubiquitin-dependent degradation of the tumor suppressor proteins PML and p27Kip1, which is characteristic in aggressive and late stages of prostate cancer [21,52].